Skip to search formSkip to main contentSkip to account menu

MGS 0039

Known as: MGS-0039, MGS0039 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PTSD-Related Behavioral Traits in a Rat Model of Blast-Induced mTBI Are Reversed by the mGluR2/3 Receptor Antagonist BCI-838
Visual Abstract Battlefield blast exposure related to improvised explosive devices (IEDs) has become the most common cause of… 
2017
2017
Prevalence of Coxiella burnetii in cattle at South Korean national breeding stock farms
This is the first study to evaluate the serologic and molecular prevalence of Coxiella burnetii in cattle at national breeding… 
Highly Cited
2016
Highly Cited
2016
Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
Abstract Background: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor… 
2015
2015
Multifunctional microstructured polymer films for boosting solar power generation of silicon-based photovoltaic modules.
We propose two-dimensional periodic conical micrograting structured (MGS) polymer films as a multifunctional layer (i.e., light… 
Highly Cited
2011
Highly Cited
2011
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
2011
2011
Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice
Highly Cited
2006
Highly Cited
2006
A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell
2006
2006
Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential.
2006
2006
IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND BIOAVAILABILITY OF ESTER PRODRUGS OF MGS0039 (3-(3,4-DICHLOROBENZYLOXY)-2-AMINO-6-FLUOROBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID), A POTENT…
MGS0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo-[3.1.0]hexane-2,6-dicarboxylic acid) has been identified as a potent… 
Highly Cited
2004
Highly Cited
2004
Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective…
Novel group II metabotropic glutamate receptor (mGluR) antagonists, 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)